Calla Lily Clinical Care
Calla Lily Clinical Care is a women’s health focused B-Corp that has developed the proprietary Callavid® platform for intravaginal drug delivery. Initial target indications are in fertility and pregnancy, where the company seeks to offer the world’s first drug-device combo product to prevent miscarriages, and for IVF luteal phase support. Callavid® can also deliver live biotherapeutics (LBPs) to reduce recurrent Bacterial Vaginosis, cutting antibiotic usage and reducing the spread of antimicrobial resistance (AMR). Further use-cases include HRT for menopause use cases, and effective medical sample collection (Lilyvid™ device) to facilitate the next generation of biomarker-based diagnostic tests for endometriosis and a wide range of other conditions. The company’s devices are built upon underlying technology named a TIME Magazine Best Invention of the Year.
Tech Stack (13 technologies)
Frequently Asked Questions
What technologies does Calla Lily Clinical Care use?+
Calla Lily Clinical Care uses 13 technologies including Flickity, Google Analytics, Google Tag Manager.
What industry is Calla Lily Clinical Care in?+
Calla Lily Clinical Care operates in the Health Care industry.
Where is Calla Lily Clinical Care based?+
Calla Lily Clinical Care is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026